Aplicacionesi Phone

Vetphage Pharmaceuticals, a company operating in the animal health industry, known for their support to Poultry farmers and Aquaculture, has been successfully rebranded to Proteon Pharmaceuticals India Pvt. Ltd. Being established in India in 2017, the Vetphage has proven to be a reliable partner for Proteon Pharmaceuticals S.A, its mother company headquartered in Poland, Europe. Proteon is a leader in bacteriophage (phage) technology for livestock farming. Proteon’s products modulate the microbiome, enhancing sustainability and improving performance on the farm. The company currently operates worldwide with footprints in Europe, APAC and Middle East.

Vetphage has shown a promising potential in the first few years of its operations. Having recorded 175% revenue increase in the first 6 months of 2020 despite the general countrywide lockdown, the company is forecasting more than 200% growth in H2 of 2020 compared to H1. “Since poultry producers are switching over to safer and efficient feed additives, we expect to see substantial growth in our sales volume and market share. A bulk of the growth is likely to accrue from the South and West markets, with sizable contributions from the North, Central and Eastern Indian regions. We expect 40% growth in revenue in the Southern region comprising AP, Karnataka, TN, Kerala, Telangana, and a 20% growth in the Western region, comprising Maharashtra and Gujarat ” said Dr Ramdas Kambale, Director of Proteon Pharmaceuticals India.

Indian Poultry market is currently valued at Rs. 10,000 crores and growing annually with a compounded growth rate of 10 percent, which is among the highest in the world.

“Proteon strives to capture the Indian market under one global brand. It’ll bring savings that we will translate to even better support our customers” said Mr. Nipun Gupta, Chief Commercial Officer at Proteon Pharmaceuticals S.A. The new approach of poultry integrators is fostering growth